Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Kathy Hibbs, Paul Billings

Premium

23andMe has appointed Kathy Hibbs to be its chief legal and regulatory officer. Previously she served as senior vice president and general counsel for Genomic Health and has also held related posts at Monogram Biosciences and Varian Medical Systems. She is active in several industry groups, including the American Clinical Laboratory Association and the Personalized Medicine Coalition. She holds a JD from the University of California, Hastings School of Law.


CollabRx has appointed Paul Billings to its board of directors. Billings is a board certified internist and clinical geneticist and most recently served as chief medical officer for Life Technologies. He is executive chairman of Melanoma Diagnostics, a director of Trovagene, and a co-founder and past medical director of the Cordblood Registry. He also was a senior vice president for corporate development at Laboratory Corporation of America and a co-founder of Omicia.

He serves on the scientific advisory board of the US Food and Drug Administration, the Genomic Medicine Advisory Committee at the Department of Veteran Affairs, and the National Academy of Sciences Institute of Medicine's Roundtable on Genomics.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.